You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Androgen Receptor Positive (AR )

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hormone Receptor-positive Breast Cancer, Hormone Receptor Positive HER-2 Negative Breast Cancer, Metastatic Breast Cancer Trial

Not yet recruiting
  • Hormone Receptor-positive Breast Cancer
  • +2 more
  • Nashville, Tennessee
    Sarah Cannon Research Institute
Oct 5, 2022

Advanced Epithelial Ovarian, Recurrent Epithelial Ovarian, Fallopian Tube Trial in United States (Enzalutamide)

Completed
  • Advanced Epithelial Ovarian
  • +3 more
  • Basking Ridge, New Jersey
  • +5 more
Mar 4, 2022

Breast Cancer, HER2-negative Breast Cancer, Metastatic Breast Cancer Trial in Madison (18F-DCFPyL)

Recruiting
  • Breast Cancer
  • +2 more
  • Madison, Wisconsin
    University of Wisconsin School of Medicine and Public Health
Oct 18, 2022

Advanced Breast Carcinoma, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8 Trial in Houston

Recruiting
  • Advanced Breast Carcinoma
  • +17 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 5, 2022

Androgen Receptor Positive, Estrogen Receptor Negative, HER2/Neu Negative Trial in United States (drug, other, biological)

Active, not recruiting
Has Results
  • Androgen Receptor Positive
  • +5 more
  • Corona, California
  • +6 more
Jun 8, 2022

Breast Cancer Trial in United States (bicalutamide, diagnostic laboratory biomarker analysis, immunohistochemistry staining

Completed
Has Results
  • Breast Cancer
  • San Francisco, California
  • +7 more
Jul 8, 2022

Locally Advanced Salivary Gland Carcinoma, Metastatic Salivary Gland Carcinoma, Recurrent Salivary Gland Carcinoma Trial

Not yet recruiting
  • Locally Advanced Salivary Gland Carcinoma
  • +3 more
  • Biopsy
  • +3 more
  • (no location specified)
Jan 10, 2023

Solid Tumor, Androgen Receptor Gene Overexpression Trial in Darlinghurst (SEVI-D (Seviteronel in combination with dexamthasone))

Terminated
  • Solid Tumor
  • Androgen Receptor Gene Overexpression
  • SEVI-D (Seviteronel in combination with dexamthasone)
  • Darlinghurst, New South Wales, Australia
    St Vincent's Hospital
Mar 2, 2021

Invasive Breast Carcinoma, Stage I Breast Cancer AJCC v7, Stage IA Breast Cancer AJCC v7 Trial in Houston (procedure, drug,

Recruiting
  • Invasive Breast Carcinoma
  • +11 more
  • Axillary Lymph Node Dissection
  • +5 more
  • Houston, Texas
  • +1 more
Mar 10, 2022

Urothelial Carcinoma Bladder, Androgen Receptor Positive Trial in Providence (Degarelix, Gemcitabine/Cisplatin)

Not yet recruiting
  • Urothelial Carcinoma Bladder
  • Androgen Receptor Positive
  • Providence, Rhode Island
    Lifespan Cancer Institute
May 1, 2023

Metastatic Triple Negative Breast Cancer Trial in Guangzhou (TPC, Bicalutamide 150 mg)

Terminated
  • Metastatic Triple Negative Breast Cancer
  • TPC
  • Bicalutamide 150 mg
  • Guangzhou, Guangdong, China
  • +1 more
Jan 26, 2021

Prospective Androgen Receptor Signaling Inhibitors Resistance

Not yet recruiting
  • Prostate Cancer
  • +3 more
    • (no location specified)
    Nov 15, 2023

    Prostatic Tumors Trial in Beijing, NanJing, ShangHai (Apalutamide)

    Active, not recruiting
    • Prostatic Neoplasms
    • Beijing, China
    • +3 more
    Jan 17, 2023

    Triple Negative Breast Cancer Trial in United States (GTx-024)

    Terminated
    Has Results
    • Triple Negative Breast Cancer
    • Fort Lauderdale, Florida
    • +6 more
    Oct 29, 2020

    Salivary Gland Carcinoma Trial in United States (Goserelin Acetate, Pembrolizumab)

    Recruiting
    • Salivary Gland Carcinoma
    • Chicago, Illinois
    • +6 more
    Sep 22, 2022

    Salivary Gland Cancer Trial in Japan (Darolutamide, Goserelin)

    Recruiting
    • Salivary Gland Cancer
    • Nagoya, Aichi, Japan
    • +11 more
    Jan 21, 2023

    Metastatic Breast Cancer Trial in United States (Orteronel)

    Completed
    Has Results
    • Metastatic Breast Cancer
    • New Haven, Connecticut
    • +9 more
    Jun 8, 2022

    Breast Cancer Trial in Beijing, Zhengzhou, Changsha (EG017)

    Not yet recruiting
    • Breast Cancer
    • Beijing, Benjing, China
    • +2 more
    Dec 30, 2022

    Estrogen Receptor Negative, Estrogen Receptor Positive, HER2/Neu Negative Trial in United States (Biomarker Analysis,

    Active, not recruiting
    Has Results
    • Estrogen Receptor Negative
    • +6 more
    • Biomarker Analysis
    • +3 more
    • Birmingham, Alabama
    • +8 more
    Feb 3, 2022

    Breast Cancer, Metastasis Trial in New York (Abemaciclib, Bicalutamide)

    Recruiting
    • Breast Cancer
    • Metastasis
    • New York, New York
    • +2 more
    Oct 14, 2021

    Prostatic Tumor Trial (AAA617, AAA517, Piflufolastat F 18)

    Not yet recruiting
    • Prostatic Neoplasm
    • (no location specified)
    Apr 27, 2023

    Breast Cancer Female, Triple Negative and Androgen Receptor Positive Trial in Caen (Darolutamide, Capecitabine)

    Active, not recruiting
    • Breast Cancer Female
    • Triple Negative and Androgen Receptor Positive
    • Caen, France
      Centre François Baclesse
    Jan 3, 2022

    Triple Negative Breast Cancer Trial (Seviteronel-D (Seivteronel in combination with dexamethasone), Docetaxel)

    Not yet recruiting
    • Triple Negative Breast Cancer
    • Seviteronel-D (Seivteronel in combination with dexamethasone)
    • Docetaxel
    • (no location specified)
    Sep 21, 2021

    Triple Negative Breast Cancer Trial in United States (ribociclib, Bicalutamide)

    Recruiting
    • Triple Negative Breast Cancer
    • Chicago, Illinois
    • +5 more
    Oct 31, 2022

    Metastatic Breast Cancer Trial in Worldwide (Enobosarm, Exemestane)

    Recruiting
    • Metastatic Breast Cancer
    • Anchorage, Alaska
    • +58 more
    Jan 6, 2023